| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers T > Headlines for Tracon Pharmaceuticals, Inc. > News item |
Tracon arranges $25 million at-the-market offering of common stock
Agent Stifel, Nicolaus conducts offering and gets a 2.5% commission
By Devika Patel
Knoxville, Tenn., Feb. 1 – Tracon Pharmaceuticals, Inc. negotiated a $25 million at-the-market equity sales agreement with Stifel, Nicolaus and Co., Inc. on Feb. 1, according to an 8-K filed Monday with the Securities and Exchange Commission.
The agent will be paid a 2.5% commission.
The clinical-stage biopharmaceutical company is based in San Diego.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.